文献速递乳房整形与再造

猪源脱细胞腹膜基质在即刻乳房重建中的多中心前瞻性单臂试验

Porcine Acellular Peritoneal Matrix in Immediate Breast Reconstruction: A Multicenter, Prospective, Single-Arm Trial.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

组织学显示细胞浸润与产品吸收,BREAST-Q满意度与现有文献一致。

要点

  • 猪源脱细胞腹膜基质可用于即刻两阶段组织扩张器乳房重建。
  • 重建失败3例(6.8%),均以伤口裂开为先兆。

核心结论

  • 制备的猪源脱细胞腹膜基质是即刻两阶段组织扩张器乳房重建的安全辅助材料。
  • 仍需进一步研究以确定其与现有商用脱细胞基质的疗效对比。

研究设计与样本

  • 评估人口学资料、手术信息、并发症、组织学特征及BREAST-Q满意度。

主要发现

  • 血清肿发生于44侧中的1侧(2.3%),血肿发生于2侧(4.6%)。
  • 伤口裂开发生于4侧(9.1%),3例受试者重建失败需取出扩张器和/或基质(6.8%),所有失败均先有伤口裂开。
  • 组织学分析显示细胞浸润与产品吸收,BREAST-Q满意度与现有文献一致。

临床怎么用

  • 可将猪源脱细胞腹膜基质作为即刻两阶段组织扩张器乳房重建的辅助材料。
  • 术后需关注伤口裂开,因其为重建失败的前兆。

局限性

  • 由企业资助。
  • 证据等级为治疗性IV级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Use of biological implants such as acellular dermal matrices in tissue expander breast reconstruction is a common adjunct to submuscular implant placement. There is a paucity of published prospective studies involving acellular matrices. The authors sought to evaluate a porcine-derived acellular peritoneal matrix product for immediate breast reconstruction. METHODS: A prospective, single-arm trial was designed to analyze safety and outcomes of immediate tissue expander-based breast reconstruction with a novel porcine-derived acellular peritoneal matrix surgical mesh implant. Twenty-five patients were enrolled in this industry-sponsored trial. Patient demographics, surgical information, complications, histologic characteristics, and satisfaction (assessed by means of the BREAST-Q questionnaire) were evaluated. RESULTS: Twenty-five patients (44 breasts) underwent mastectomy with immediate breast reconstruction using tissue expanders with acellular peritoneal matrix. Sixteen reconstructed breasts experienced at least one complication (36 percent). Seroma and hematoma occurred in one of 44 (2.3 percent) and two of 44 breasts (4.6 percent), respectively. Wound dehiscence occurred in four of 44 breasts (9.1 percent). Three subjects experienced reconstruction failure resulting in expander and/or acellular peritoneal matrix removal (6.8 percent); all failures were preceded by wound dehiscence. Histologic analysis showed cellular infiltration and product resorption. Results of the BREAST-Q demonstrated a level of postoperative patient satisfaction consistent with results in the available literature. CONCLUSIONS: Prepared porcine-derived acellular peritoneal matrix is a safe adjunct in immediate two-stage tissue expander-based breast reconstruction. Further studies are required to determine efficacy compared to current commercially available acellular matrices. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Simpson AM, Higdon KK, Kilgo MS, et al. Porcine Acellular Peritoneal Matrix in Immediate Breast Reconstruction: A Multicenter, Prospective, Single-Arm Trial. Plast Reconstr Surg. 2019. PMID: 30589773. doi:10.1097/PRS.0000000000005095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。